The site is responsible for Innovation, Development, Manufacturing and Strategic brand management for aesthetic and corrective treatments. A majority of the products in the aesthetic & corrective portfolio is based on the company’s patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid. The manufacturing site employs 170 people and has served the market worldwide with leading brands like Restylane and Macrolane since 1996.